ePrivacy and GPDR Cookie Consent by TermsFeed Generator

AZACITIDINE AQVIDA

25MG/ML INJ PLV SUS 1X150MG

SÚKL code 0242740
Name of the product AZACITIDINE AQVIDA
_MA_MEDICATION_DETAIL_INFO_MED_NAME i AZACITIDINE AQVIDA
Supplement 25MG/ML INJ PLV SUS 1X150MG
Strenght 25MG/ML
Pharmaceutical form Powder for suspension for injection
Package 1X150MG
Route Subcutaneous use
Language of the pack Czech
Wrap type Vial
Legal status na lékařský předpis
Active substance AZACITIDINE (AZACITIDINUM)
ATC group L01BC07
ATC group name AZACITIDIN

Marketing authorisation information

Registration Number 44/ 120/19-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 12. 2021
MA Holder AqVida GmbH, Hamburg
MA Holder country NĚMECKO
Actual MA holder EVER-Valinject GmbH, Unterach am Attersee
Actual MA holder country RAKOUSKO

Back to list